TheCDKN2A/p16INK4a5′UTR sequence and translational regulation: impact of novel variants predisposing to melanoma

Genetics of familial melanoma: 20 years afterCDKN2A

(2015) Lauren G. Aoude et al.   Pigment Cell & Melanoma Research

A highly recurrent RPS27 5’UTR mutation in melanoma

(2015) Ken Dutton-Regester et al.   Oncotarget

p53-directed translational control can shape and expand the universe of p53 target genes

(2014) S Zaccara et al.   CELL DEATH AND DIFFERENTIATION

CDKN2AUnclassified Variants in Familial Malignant Melanoma: Combining Functional and Computational Approaches for Their Assessment

(2014) Maria Chiara Scaini et al.   HUMAN MUTATION

Beyond GWASs: Illuminating the Dark Road from Association to Function

(2013) Stacey L. Edwards et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Analysis of Latvian familial melanoma patients shows novel variants in the noncoding regions of CDKN2A and that the CDK4 mutation R24H is a founder mutation

(2013) Rūta Veinalde et al.   MELANOMA RESEARCH

Mutational landscape and significance across 12 major cancer types

(2013) Cyriac Kandoth et al.   NATURE

Association between putative functional variants in thePSMB9gene and risk of melanoma - re-analysis of published melanoma genome-wide association studies

(2013) Ji Qian et al.   Pigment Cell & Melanoma Research

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

MC1Rvariation and melanoma risk in relation to host/clinical and environmental factors inCDKN2Apositive and negative melanoma patients

(2012) Paola Ghiorzo et al.   EXPERIMENTAL DERMATOLOGY

Familial Melanoma–Associated Mutations in p16 Uncouple its Tumor-Suppressor Functions

(2012) Noah C. Jenkins et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Familial melanoma: Clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family

(2012) Eve Maubec et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history

(2012) P. Ghiorzo et al.   Pigment Cell & Melanoma Research

Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy

(2011) Chiara Menin et al.   Pigment Cell & Melanoma Research

p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System

(2011) Virginia Andreotti et al.   PLoS One

Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom

(2010) J. A. Newton-Bishop et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Functional analysis of CDKN2A/p16INK4a 5′-UTR variants predisposing to melanoma

(2010) Alessandra Bisio et al.   HUMAN MOLECULAR GENETICS

Predicting functional significance of cancer-associated p16INK4a mutations in CDKN2A

(2010) Heather A. McKenzie et al.   HUMAN MUTATION

Functional, structural, and genetic evaluation of 20CDKN2Agerm line mutations identified in melanoma-prone families or patients

(2009) Caroline Kannengiesser et al.   HUMAN MUTATION

Clinical genetic testing for familial melanoma in Italy: A cooperative study

(2009) William Bruno et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Functional impairment of p16INK4A due to CDKN2A p.Gly23Asp missense mutation

(2009) Maria Chiara Scaini et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma

(2008) L. Pastorino et al.   Pigment Cell & Melanoma Research

Wild type and melanoma-associated mutant p16INK4aproteins do not oligomerize in vivo

(2008) Heather McKenzie et al.   Pigment Cell & Melanoma Research